Karuna Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;'>KT</div>
KRTX -- USA Stock  

USD 81.07  0.43  0.53%

Karuna Stock News module provides quick insight into current market opportunities from investing in Karuna Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Karuna Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Please see Karuna Therapeutics Hype Analysis, Karuna Therapeutics Correlation and Karuna Therapeutics Performance.

Search Today's Stock News

 
Refresh
Karuna Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Karuna daily returns and investor perception about the current pice of Karuna Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Exercise or conversion by Pande Atul of 5000 shares of Karuna Therapeutics subject to Rule 16b-3
Filed transaction by Karuna Therapeutics Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Karuna insider trading alert for exercise of option (right to buy) by Pande Atul, the corporate stakeholder, on 18th of September 2020. This event was filed by Karuna Therapeutics Inc with SEC on 2020-09-18. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Current Asset

Current Asset Comparative Analysis

Karuna Therapeutics is currently under evaluation in current asset category among related companies. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Peers

Karuna Therapeutics Related Equities

DNLIDenali Therapeutics   11.52   
0%
100.0%
DRNADicerna Pharmaceuticals   9.49   
0%
82.0%
EDITEditas Medicine   0.76   
6.0%
0%
EQEquillium   1.37   
11.0%
0%
DMACDiaMedica Therapeutics   1.39   
12.0%
0%
DYAIDYADIC INTERNATIONAL INC   1.42   
12.0%
0%
NKNantKwest   2.68   
23.0%
0%
EARSAuris Medical Holding   3.45   
29.0%
0%
DVAXDynavax Technologies Corporation   6.97   
60.0%
0%
DTILPrecision BioSciences   7.59   
65.0%
0%
Please see Karuna Therapeutics Hype Analysis, Karuna Therapeutics Correlation and Karuna Therapeutics Performance. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.